Circle Unicorn News: Circle Pharma And Boehringer Ingelheim Forge Cancer Treatment Alliance

Circle Unicorn News - October 11, 2024

Circle Pharma and Boehringer Ingelheim have announced a new partnership to develop a precision cancer treatment targeting cyclin-dependent kinases. This collaboration could potentially lead to innovative treatments for hard-to-treat cancers.

Sources
https://www.pharmaceutical-technology.com/news/boehringer-circle-cancer-treatment/

Outline
(00:00:00) Introduction
(00:00:32) Circle Pharma Partners with Boehringer to Develop New Cancer Treatment

About Linqto
At Linqto, we empower investors with real-time insights and access to private AI companies, ensuring you stay ahead in the fast-evolving tech landscape. Our platform provides unparalleled opportunities to invest in high-potential startups and unicorns before they go public.

View Linqto Products: https://www.linqto.com/products/
Find all the Unicorn News on Linqto: https://www.linqto.com/unicorn-news/View Circle on Linqto: https://www.linqto.com/products/circle